AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
Income Statement
Earnings Waterfall
AcelRx Pharmaceuticals Inc
Revenue
|
620k
USD
|
Operating Expenses
|
-20.6m
USD
|
Operating Income
|
-20m
USD
|
Other Expenses
|
-6.5m
USD
|
Net Income
|
-26.5m
USD
|
Income Statement
AcelRx Pharmaceuticals Inc
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
4
N/A
|
30
+724%
|
29
-3%
|
28
-1%
|
33
+15%
|
5
-84%
|
5
+2%
|
7
+35%
|
18
+148%
|
19
+8%
|
22
+15%
|
25
+12%
|
13
-49%
|
17
+37%
|
17
+1%
|
16
-11%
|
14
-12%
|
8
-42%
|
5
-35%
|
3
-35%
|
2
-33%
|
2
-6%
|
2
-3%
|
2
+6%
|
2
+10%
|
2
-6%
|
2
+6%
|
4
+82%
|
5
+17%
|
5
+5%
|
6
+2%
|
3
-45%
|
4
+16%
|
3
-21%
|
2
-18%
|
2
-19%
|
0
N/A
|
2
N/A
|
0
-86%
|
1
+100%
|
1
+24%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(5)
|
(8)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(11)
|
(8)
|
(5)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(5)
|
(4)
|
(4)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
0
N/A
|
17
N/A
|
1
-93%
|
1
-27%
|
2
+83%
|
5
+190%
|
5
-9%
|
2
-53%
|
1
-62%
|
(3)
N/A
|
(2)
+9%
|
(1)
+39%
|
(1)
+3%
|
(2)
-29%
|
(2)
-11%
|
(3)
-46%
|
(4)
-35%
|
(5)
-13%
|
(5)
-4%
|
(2)
+52%
|
(1)
+47%
|
(1)
+48%
|
(0)
+97%
|
(2)
-10 750%
|
(0)
+88%
|
(1)
-248%
|
0
N/A
|
0
N/A
|
0
N/A
|
(1)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(38)
|
(36)
|
(33)
|
(37)
|
(38)
|
(43)
|
(45)
|
(43)
|
(41)
|
(37)
|
(34)
|
(34)
|
(34)
|
(37)
|
(40)
|
(39)
|
(39)
|
(36)
|
(32)
|
(31)
|
(31)
|
(34)
|
(38)
|
(43)
|
(46)
|
(50)
|
(53)
|
(49)
|
(46)
|
(40)
|
(34)
|
(35)
|
(37)
|
(35)
|
(34)
|
(29)
|
(23)
|
(31)
|
(28)
|
(22)
|
(21)
|
|
Selling, General & Administrative |
(8)
|
(10)
|
(12)
|
(15)
|
(17)
|
(18)
|
(19)
|
(17)
|
(15)
|
(14)
|
(13)
|
(14)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(16)
|
(16)
|
(17)
|
(21)
|
(27)
|
(34)
|
(40)
|
(45)
|
(48)
|
(45)
|
(41)
|
(36)
|
(31)
|
(32)
|
(33)
|
(31)
|
(27)
|
(23)
|
(18)
|
(26)
|
(18)
|
(17)
|
(15)
|
|
Research & Development |
(30)
|
(26)
|
(22)
|
(23)
|
(22)
|
(25)
|
(26)
|
(26)
|
(26)
|
(22)
|
(20)
|
(19)
|
(19)
|
(21)
|
(24)
|
(23)
|
(22)
|
(19)
|
(16)
|
(14)
|
(14)
|
(13)
|
(11)
|
(9)
|
(6)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(5)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
|
Operating Income |
(35)
N/A
|
(7)
+81%
|
(5)
+30%
|
(9)
-97%
|
(6)
+35%
|
(38)
-539%
|
(40)
-6%
|
(36)
+10%
|
(23)
+34%
|
(19)
+18%
|
(17)
+11%
|
(17)
-1%
|
(32)
-87%
|
(32)
+1%
|
(36)
-11%
|
(37)
-5%
|
(38)
-2%
|
(39)
-2%
|
(35)
+10%
|
(32)
+8%
|
(33)
-1%
|
(36)
-10%
|
(40)
-11%
|
(46)
-16%
|
(50)
-9%
|
(54)
-8%
|
(58)
-6%
|
(51)
+11%
|
(47)
+9%
|
(41)
+12%
|
(34)
+16%
|
(37)
-9%
|
(37)
+1%
|
(36)
+3%
|
(32)
+12%
|
(27)
+16%
|
(23)
+15%
|
(32)
-40%
|
(27)
+14%
|
(21)
+22%
|
(20)
+6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(17)
|
(17)
|
(16)
|
(4)
|
4
|
4
|
7
|
4
|
(2)
|
(1)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
(0)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
5
|
5
|
7
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5)
|
(5)
|
(5)
|
0
|
(0)
|
(0)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(5)
|
(7)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(12)
|
(10)
|
(9)
|
(5)
|
(1)
|
1
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
87
|
86
|
85
|
85
|
0
|
0
|
|
Pre-Tax Income |
(52)
N/A
|
(23)
+55%
|
(20)
+13%
|
(13)
+34%
|
(2)
+87%
|
(33)
-1 784%
|
(34)
-1%
|
(32)
+5%
|
(27)
+16%
|
(24)
+12%
|
(25)
-4%
|
(27)
-9%
|
(44)
-65%
|
(43)
+2%
|
(48)
-11%
|
(50)
-4%
|
(51)
-3%
|
(52)
-2%
|
(48)
+8%
|
(46)
+5%
|
(45)
+1%
|
(47)
-4%
|
(49)
-4%
|
(51)
-4%
|
(51)
-1%
|
(53)
-4%
|
(55)
-4%
|
(50)
+10%
|
(46)
+8%
|
(40)
+12%
|
(33)
+17%
|
(37)
-10%
|
(36)
+2%
|
(35)
+3%
|
(31)
+12%
|
53
N/A
|
57
+7%
|
48
-16%
|
62
+30%
|
(16)
N/A
|
(13)
+19%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
35
|
0
|
35
|
35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
0
|
|
Income from Continuing Operations |
(52)
|
(23)
|
(20)
|
(13)
|
(2)
|
(33)
|
(34)
|
(32)
|
(28)
|
(24)
|
(25)
|
(28)
|
(44)
|
(43)
|
(48)
|
(50)
|
(51)
|
(17)
|
(13)
|
(11)
|
(10)
|
(47)
|
(49)
|
(51)
|
(51)
|
(53)
|
(55)
|
(50)
|
(46)
|
(40)
|
(33)
|
(37)
|
(36)
|
(35)
|
(31)
|
53
|
57
|
48
|
62
|
(16)
|
(13)
|
|
Net Income (Common) |
(52)
N/A
|
(23)
+55%
|
(20)
+13%
|
(13)
+34%
|
(2)
+87%
|
(33)
-1 784%
|
(34)
-1%
|
(32)
+5%
|
(28)
+14%
|
(24)
+12%
|
(25)
-4%
|
(28)
-9%
|
(44)
-60%
|
(43)
+2%
|
(48)
-11%
|
(50)
-4%
|
(51)
-3%
|
(52)
0%
|
(48)
+8%
|
(45)
+5%
|
(44)
+1%
|
(47)
-6%
|
(49)
-4%
|
(51)
-4%
|
(51)
-1%
|
(53)
-4%
|
(55)
-4%
|
(50)
+10%
|
(46)
+8%
|
(40)
+12%
|
(33)
+17%
|
(37)
-10%
|
(36)
+2%
|
(35)
+3%
|
(34)
+3%
|
40
N/A
|
41
+4%
|
42
+3%
|
36
-15%
|
(32)
N/A
|
(26)
+17%
|
|
EPS (Diluted) |
-24.98
N/A
|
-11.79
+53%
|
-9.39
+20%
|
-6.18
+34%
|
-0.79
+87%
|
-15.36
-1 844%
|
-15.41
0%
|
-14.45
+6%
|
-12.3
+15%
|
-10.99
+11%
|
-11.22
-2%
|
-12.13
-8%
|
-19.39
-60%
|
-19.01
+2%
|
-21.02
-11%
|
-21.88
-4%
|
-22.11
-1%
|
-22.01
+0%
|
-18.64
+15%
|
-17.38
+7%
|
-14.82
+15%
|
-16.14
-9%
|
-12.49
+23%
|
-12.93
-4%
|
-12.93
N/A
|
-13.45
-4%
|
-13.87
-3%
|
-12.33
+11%
|
-10.42
+15%
|
-9.47
+9%
|
-5.9
+38%
|
-6.15
-4%
|
-6.05
+2%
|
-5.86
+3%
|
-4.62
+21%
|
5.31
N/A
|
5.57
+5%
|
5.71
+3%
|
3.31
-42%
|
-2.93
N/A
|
-1.57
+46%
|